Schulte to co-lead the development and management of the portfolio to fuel innovation in health care
SAN FRANCISCO, Calif., August 10, 2015 – McKesson Ventures, the venture capital arm of McKesson Corporation, today announced that Dave Schulte has been appointed managing director, effective September 8, 2015. Schulte joins McKesson from Kaiser Permanente Ventures where he served as vice president and managing director. In his role at McKesson, Schulte will be responsible for co-leading the development and management of the McKesson Ventures portfolio alongside group leader Tom Rodgers.
McKesson Ventures, established in December 2014, has made minority investments in Carena, a telemedicine provider; Accolade, a concierge health care navigation and employee health engagement platform; PipelineRx, a technology and services platform company focused on telepharmacy, and Rock Health’s seed fund, among others. The fund targets companies that are both enabling and benefitting from disruptive changes affecting the health care industry, including increasing consumerism, emergence of alternate delivery models and the shift towards value based care.
“Dave is a well-respected, active investor in the areas of health care where we are focused and adding him to the team will help us continue to grow the fund and develop our portfolio,” said Tom Rodgers, senior vice president and managing director, McKesson Ventures. “At Kaiser Permanente, he demonstrated how a strategic investor can optimize its partnership with early stage companies to build value for both sides.”
Schulte has more than 17 years of experience as an investor and investment banker, partnering with entrepreneurs to grow innovative health care and technology businesses. He joined Kaiser Permanente Ventures in 2003 and helped build the investment program from $20M to $400M of assets under management. Schulte led Kaiser Permanente Ventures’ investment team, whose IT and Digital Health investments include: Ginger.io, Health Catalyst, Ingenious Med, KitCheck, MetricStream, Omada Health, Proteus Digital Health, Validic, and Rock Health’s seed fund.
Prior to KP Ventures, Schulte was a software and health care investment banker at J.P. Morgan (Hambrecht & Quist), UBS, and Piper Jaffray. He is a graduate of St. John's University and earned a Master of Public Policy degree from Harvard University.
About McKesson Ventures
McKesson Ventures is the venture capital arm of McKesson Corporation specializing in early and growth stage companies. McKesson Ventures targets companies that both catalyze and benefit from the key changes taking place in the U.S. health care landscape. McKesson Corporation, currently ranked 11th on the FORTUNE 500, is a health care services and information technology company dedicated to making the business of health care run better. We work with payers, hospitals, physician offices, pharmacies, pharmaceutical companies, and others across the spectrum of care to build healthier organizations that help deliver better care to patients in every setting. Visit www.McKessonventures.com to learn more.